Article Details

MHRA Approves XEVUDY® (sotrovimab), GlaxoSmithKline and Vir Biotechnology's ...

Retrieved on: 2021-12-08 03:13:48

Tags for this article:

Click the tags to see associated articles and topics

MHRA Approves XEVUDY® (sotrovimab), GlaxoSmithKline and Vir Biotechnology's .... View article details on hiswai:

Excerpt

Brand Institute is proud to announce its successful partnership with GlaxoSmithKline and Vir Biotechnology in developing the brand name XEVUDY®, ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up